» Articles » PMID: 1985093

Purification and Characterization of a Major Human Pneumocystis Carinii Surface Antigen

Overview
Journal J Clin Invest
Specialty General Medicine
Date 1991 Jan 1
PMID 1985093
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Previous studies of Pneumocystis carinii have identified the major surface antigen of rat and human isolates as proteins of 116,000 and 95,000 mol wt, respectively, that are antigenically not identical. In this study both rat and human P. carinii proteins were purified by solubilization with zymolyase followed by molecular sieve and ion exchange chromatography. The native proteins had an apparent mol wt of 290,000 or greater, based on molecular sieve studies as well as cross-linking studies. Both proteins were glycoproteins; treatment with endoglycosidase H resulted in a 9% decrease in mol wt. The carbohydrate composition of the rat P. carinii glycoprotein was distinct from the human isolate; glucose, mannose, galactose, and glucosamine occurred in approximately equimolar ratios in the human P. carinii protein, whereas glucose and mannose were the predominant sugars of the rat P. carinii protein. To evaluate humoral immune responses to the human P. carinii protein, an enzyme-linked immunosorbent assay using purified protein was developed. Some, but not all, patients who subsequently developed P. carinii pneumonia demonstrated a serum antibody response to the surface antigen. Nearly all subjects without a history of P. carinii pneumonia had no detectable antibodies. Purified P. carinii proteins will greatly facilitate the investigation of host-P. carinii interactions.

Citing Articles

CD40 Expression by B Cells Is Required for Optimal Immunity to Murine Pneumocystis Infection.

Sassi M, Curran S, Bishop L, Liu Y, Kovacs J J Infect Dis. 2024; 230(4):1033-1041.

PMID: 38478734 PMC: 11481328. DOI: 10.1093/infdis/jiae133.


CD40 Expression by B cells is Required for Optimal Immunity to Murine Infection.

Sassi M, Curran S, Bishop L, Liu Y, Kovacs J bioRxiv. 2024; .

PMID: 38410485 PMC: 10896351. DOI: 10.1101/2024.02.05.578900.


Pneumocystis carinii Major Surface Glycoprotein Dampens Macrophage Inflammatory Responses to Fungal β-Glucan.

Kottom T, Hebrink D, Carmona E, Limper A J Infect Dis. 2020; 222(7):1213-1221.

PMID: 32363390 PMC: 7459132. DOI: 10.1093/infdis/jiaa218.


Pathogenic Fungal Infection in the Lung.

Li Z, Lu G, Meng G Front Immunol. 2019; 10:1524.

PMID: 31333658 PMC: 6616198. DOI: 10.3389/fimmu.2019.01524.


Is the unique camouflage strategy of Pneumocystis associated with its particular niche within host lungs?.

Hauser P PLoS Pathog. 2019; 15(1):e1007480.

PMID: 30677096 PMC: 6345417. DOI: 10.1371/journal.ppat.1007480.


References
1.
Laemmli U . Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5259):680-5. DOI: 10.1038/227680a0. View

2.
Tanabe K, Furuta T, Ueda K, Tanaka H, Shimada K . Serological observations of Pneumocystis carinii infection in humans. J Clin Microbiol. 1985; 22(6):1058-60. PMC: 271881. DOI: 10.1128/jcm.22.6.1058-1060.1985. View

3.
Norman L, KAGAN I . Some observations on the serology of Pneumocystis carinii infections in the United States. Infect Immun. 1973; 8(3):317-21. PMC: 422850. DOI: 10.1128/iai.8.3.317-321.1973. View

4.
Meuwissen J, Tauber I, Leeuwenberg A, Beckers P, Sieben M . Parasitologic and serologic observations of infection with Pneumocystis in humans. J Infect Dis. 1977; 136(1):43-9. DOI: 10.1093/infdis/136.1.43. View

5.
Masur H, Jones T . The interaction in vitro of Pneumocystis carinii with macrophages and L-cells. J Exp Med. 1978; 147(1):157-70. PMC: 2184105. DOI: 10.1084/jem.147.1.157. View